Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant files official complaint about Allergan with Canadian regulator
Marketwatch
Thursday, July 24, 2014 - 8:40am
tags:
Canada, Valeant Pharmaceuticals, Allergan, M&A
Biotech Giant Blows Away Expectations After Selling $3.5 Billion Of Its 'Wonder Drug'
Yahoo/Business Insider
Thursday, July 24, 2014 - 8:35am
tags:
Gilead Sciences, Sovaldi, earnings
Will FDA Labelling Be MannKind's Downfall?
Motley Fool
Thursday, July 24, 2014 - 8:31am
tags:
FDA, labeling, diabetes, Afrezza, MannKind
Celgene profit rises 25 pct up on higher cancer drug sales
Yahoo/Reuters
Thursday, July 24, 2014 - 8:30am
tags:
Celgene, earnings
Lilly Profit Beats Estimates on Sales of Diabetes Drug
Bloomberg
Thursday, July 24, 2014 - 8:25am
tags:
earnings, Eli Lilly
Bristol-Myers Tops Earnings Estimates on Drug Sales
Bloomberg
Thursday, July 24, 2014 - 8:24am
tags:
Bristol-Myers Squibb, earnings
Will Bristol-Myers Squibb (BMY) Disappoint This Earnings Season?
Yahoo/Zacks.com
Wednesday, July 23, 2014 - 6:34pm
tags:
earnings, Bristol-Myers Squibb
Did Boehringer Ingelheim Withhold Pradaxa Data From Regulators?
WSJ Online
Wednesday, July 23, 2014 - 6:29pm
tags:
Pradaxa, Boehringer Ingelheim
Vertex Is Poised For An Earnings Breakout
Yahoo/Benzinga
Wednesday, July 23, 2014 - 6:27pm
tags:
earnings, Vertex Pharmaceuticals
Boston Scientific Rises on Launch of POLARIS Imaging System
Yahoo/Zacks.com
Wednesday, July 23, 2014 - 6:16pm
tags:
Boston Scientific, Polaris Imaging System, Arthroscopy Devices Market, intravascular imaging
Afrezza Is A Brilliant Technology Without A Compelling Marketing Story
Seeking Alpha
Wednesday, July 23, 2014 - 6:14pm
tags:
Afrezza, diabetes, MannKind, inhaled insulin
Gilead Sciences Beats Earnings Forecasts, Sovaldi Sales Strong, Shares Slump
Barron's
Wednesday, July 23, 2014 - 6:09pm
tags:
Gilead Sciences, earnings, Sovaldi
Is Inovio Undervalued After Positive HPV Therapy Results?
Seeking Alpha
Wednesday, July 23, 2014 - 6:06pm
tags:
Inovio, HPV, VGX-3100, vaccines, cervical cancer
Earnings Preview: Lilly counts on newer drugs to drive revenue
The Fly on the Wall
Wednesday, July 23, 2014 - 4:34pm
tags:
Eli Lilly, earnings
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wednesday, July 23, 2014 - 4:33pm
tags:
FDA, Zydelig, Gilead Sciences, chronic lymphocytic leukemia, follicular lymphoma, small lymphocytic lymphoma
Ominous Signs For Valeant In The Allergan Q2 Earnings Call
Seeking Alpha
Wednesday, July 23, 2014 - 4:30pm
tags:
earnings, Valeant Pharmaceuticals, Allergan
Inovio Declares Spin-Laden Victory With DNA Vaccine
TheStreet.com
Wednesday, July 23, 2014 - 11:05am
tags:
Inovio, vaccines, DNA vaccines, cervical cancer
How Teva Pharmaceutical Is Attacking the Generics to Defend Its Turf
TheStreet.com
Wednesday, July 23, 2014 - 11:03am
tags:
Teva Pharmaceutical, generics, Copaxone
Abuse of U.S. generic-drug rules costs consumers billions, report says
Yahoo/Reuters
Wednesday, July 23, 2014 - 10:47am
tags:
generics, FDA
Too Early To Tell For Atara Biotherapeutics IPO
Seeking Alpha
Wednesday, July 23, 2014 - 10:41am
tags:
Atara, IPOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.